Ketamine & Related Compounds for Psychiatric Disorders
The Ketamine International Journal Club runs on second and fourth Tuesdays at 5.30pm GMT. Details of the Ketamine2021 conference, which will run March 25th and 26th 2-6pm online are also posted here.
- Consultant Psychiatrist
I am interested in treatment-resistant depression and dementia. Clinically, I lead the Oxfordshire ECT and ketamine services and run a memory clinic. My main focus is developing policy and monitoring arrangements for rapidly acting antidepressants such as ketamine. I lead an international online journal club and chair the steering committee of an international academic conference on Ketamine and Related Compounds for Psychiatric Disorders. I work on ways of optimizing the effects of ketamine and am national CI and local PI for trials of rapidly acting antidepressants. Following an NIHR-funded case series exploring the use of repeated ketamine for resistant depression, we have now treated over 300 patients and are continuing to refine treatment protocols. I chair the Royal College of Psychiatrists Committee on ECT and related treatments. I led a qualitative study of ECT, which led to the creation of a Healthtalk module of patients talking about their experience and an exploration of why experiences are so polarised. When I was Coordinating Editor of the Cochrane Dementia and Cognitive Improvement Group, I led programmes on reviews of diagnostic test accuracy, and modifiable risk factors for dementia. I support NIHR funded and commercial dementia and antidepressant trials as local PI.